Potential Biomedical Limitations of Graphene Nanomaterials
DOI: https://doi.org/10.2147/IJN.S402954
IF: 7.033
2023-03-31
International Journal of Nanomedicine
Abstract:Ge Ban, 1 Yingze Hou, 2 Zhean Shen, 3 Jingjing Jia, 1 Lei Chai, 1 Chongyang Ma 1 1 School of Intelligent Medical Engineering, Sanquan College of Xinxiang Medical University, Xinxiang, 453003, People's Republic of China; 2 Clinical Medical College, Sanquan College of Xinxiang Medical University, Xinxiang, 453003, People's Republic of China; 3 Department of Biomedical Research, Research and Innovation Center, Xinjiang Institute of Technology, Xinjiang, 843100, People's Republic of China Correspondence: Ge Ban, Email Graphene-family nanomaterials (GFNs) possess mechanical stiffness, optical properties, and biocompatibility making them promising materials for biomedical applications. However, to realize the potential of graphene in biomedicine, it must overcome several challenges that arise when it enters the body's circulatory system. Current research focuses on the development of tumor-targeting devices using graphene, but GFNs accumulated in different tissues and cells through different pathways, which can cause toxic reactions leading to cell apoptosis and body dysfunction when the accumulated amount exceeds a certain limit. In addition, as a foreign substance, graphene can induce complex inflammatory reactions with immune cells and inflammatory factors, potentially enhancing or impairing the body's immune function. This review discusses the biomedical applications of graphene, the effects of graphene materials on human immune function, and the biotoxicity of graphene materials. Keywords: graphene family nanomaterials, biomedical, biocompatibility, biomedical limitation, immune system In the past decade, graphene family nanomaterials (GFNs) have been extensively utilized due to their unique surface chemistry and remarkable conductivity. Since their discovery, GFNs have attracted considerable attention from researchers 1,2 in various fields, including biology, physics, chemistry, and medicine for further investigation. 3–6 In addition, the unique structure of GFNs not only makes it the thinnest known material but also imparts exceptional physical and chemical properties to graphene. 7 As a result, GFNs have a wide range of potential applications, such as circuit elements and coating materials 8–12 and have received considerable attention in areas such as inks, 13,14 3D printing, 15,16 composite, and others. 17–19 The extensive use of graphene has also stimulated the development of graphene-derived materials (Figure 1). Figure 1 GFNs in biomedical, 3D printing, composite, ink and coating materials. The use of nanoparticles is a multi-disciplinary area of research and application, encompassing diverse fields such as physics, 20 chemistry, 21 materials science, 22 agriculture, 23 and medicine. 24 Nanoparticles have attracted considerable interest among scientists due to their ability to be freely designed, their high yield, and their potential to be customized to possess specific efficacies. 25 As a result, the development and research of nanoparticles have provided both theoretical support and practical opportunities for the drug delivery system (DDS) in the human body. The integration of nanoparticles in the fields of biochemistry and medicine has led to the emergence of a new interdisciplinary field focused on nanoparticle research in biomedicine. There has been an increase in the number of researchers involved in this emerging field, which has made significant progress in diverse areas such as vaccine production, 26 drug delivery, 27 and anti-cancer research and development. 28 Of particular interest to researchers are the new materials based on carbon nanostructures, 29 due to their large surface area and photothermal effect, which have been widely used in other fields. Among carbon nanostructures, research on graphene family nanomaterials in the biomedical field is increasing every year. 30–37 In the last decade, numerous researchers have identified and reported applications of innovative nanomaterials in the biomedical field. Among these applications, GNFs have been used in drug delivery systems, 38–41 biomedical sensing, 42–45 tumor-targeted therapy, 46–53 tissue engineering, and other areas. 54–57 Therefore, further advances in GFNs have the potential to significantly change the current landscape of biomedicine. This review article aims to provide an overview of the literature to date regarding the use of GNFs in the areas of tumor therapy, drug delivery, and antibacterial activity. In addition, this paper, will analyze the potential risks of GNFs to the human body by coll -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology